Cashu
ImmunityBio's Anktiva Gains EMA Recommendation for Bladder Cancer Treatment Advancement
about 1 month ago
Stocks
Health Care
ibrx
ImmunityBio
NASDAQ: IBRX
+1.58 (+39.87%)
5.525
USD
At close at Jan 16, 21:39 UTC
Latest ImmunityBio News
prnewswire.com
Functional Force: Precision Platforms Disrupt the 2026 Tumor Landscape
about 23 hours ago
benzinga.com
ImmunityBio Moves Closer To EU Approval For Bladder Cancer Therapy
about 1 month ago
benzinga.com
Micron, Endeavour Silver, First Majestic Silver, Applied Digital And Other Big Stocks Moving Higher On Friday
about 2 months ago
prnewswire.com
Cancer Immunotherapy Surge Drives $258B Market as FDA Accelerates Approvals
4 months ago
cnbc.com
Four meme stocks with high social activity and hedge funds shorts, according to JPMorgan
4 months ago
benzinga.com
What's Going On With ImmunityBio Shares Tuesday?
5 months ago
benzinga.com
LA Times Going Public? Patrick Soon-Shiong Plans Green Bay-Style Ownership To 'Democratize' 143-Year-Old Paper
6 months ago
cnbc.com
Stocks making the biggest moves midday: D-Wave Quantum, Moderna, Agilysys, Tesla and more
8 months ago
benzinga.com
ImmunityBio Slapped With FDA Refusal To File Letter For Expanded Use Of Its Bladder Cancer Drug
9 months ago
benzinga.com
Netflix, CNA Financial And Other Big Stocks Moving Lower In Monday's Pre-Market Session
9 months ago
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.